MA35168B1 - Combination of panobinostat and ruxolitinib in the treatment of cancer such as myeloproliferative neoplasm - Google Patents

Combination of panobinostat and ruxolitinib in the treatment of cancer such as myeloproliferative neoplasm

Info

Publication number
MA35168B1
MA35168B1 MA36539A MA36539A MA35168B1 MA 35168 B1 MA35168 B1 MA 35168B1 MA 36539 A MA36539 A MA 36539A MA 36539 A MA36539 A MA 36539A MA 35168 B1 MA35168 B1 MA 35168B1
Authority
MA
Morocco
Prior art keywords
combination
ruxolitinib
panobinostat
cancer
treatment
Prior art date
Application number
MA36539A
Other languages
French (fr)
Inventor
Thomas Radimerski
Fabienne Baffert
Brian Gadbaw
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/042174 external-priority patent/WO2012174061A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA35168B1 publication Critical patent/MA35168B1/en

Links

Abstract

L'invention concerne une combinaison qui comprend : (a) composé a ((r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile) de la formule (a) :The invention relates to a combination which comprises: (a) a ((r) -3- (4- (7h-pyrrolo [2,3-d] pyrimidin-4-yl) -1h-pyrazol-1-yl compound 3-cyclopentylpropanenitrile) of the formula (a):

MA36539A 2011-06-14 2013-12-06 Combination of panobinostat and ruxolitinib in the treatment of cancer such as myeloproliferative neoplasm MA35168B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161496750P 2011-06-14 2011-06-14
PCT/US2012/042174 WO2012174061A1 (en) 2011-06-14 2012-06-13 Combination of panobinostat and ruxolitinib in the treatment of cancer such as a myeloproliferative neoplasm

Publications (1)

Publication Number Publication Date
MA35168B1 true MA35168B1 (en) 2014-06-02

Family

ID=51581891

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36539A MA35168B1 (en) 2011-06-14 2013-12-06 Combination of panobinostat and ruxolitinib in the treatment of cancer such as myeloproliferative neoplasm

Country Status (2)

Country Link
MA (1) MA35168B1 (en)
UA (1) UA112645C2 (en)

Also Published As

Publication number Publication date
UA112645C2 (en) 2016-10-10

Similar Documents

Publication Publication Date Title
MA35861B1 (en) Kinase inhibitor regulating the signals of apoptosis
MA39211B1 (en) Tricyclic compounds as anti-cancer agents
MA39172A1 (en) Heterocyclic bicyclic derivatives as bromodomaine inhibitors
MA38624A1 (en) Biheteroaryl compounds and their uses
NZ700928A (en) Dna-pk inhibitors
EA201490912A1 (en) DERIVATIVES [1,2,3] TRIAZOLO [4,5-D] Pyrimidine as Agonists of Cannabinoid Receptor 2
EA201590930A1 (en) DOSAGE FORMS OF RUXOLITINIB WITH Slow Release.
EA201100580A1 (en) IMIDAZOPIRIDAZINCARBONITRILE USED AS KINASE INHIBITORS
EA201690357A1 (en) DOSAGE FORMS WITH Slow Release For JAK1 Inhibitor
EA201101650A1 (en) NEW PYRIMIDINE DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF MALIGNANT NONFORMS AND THE FOLLOWING DISEASES
MA34837B1 (en) INDOLIC COMPOUNDS OR ANALOGS THEREFOR USEFUL IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD)
MA37866B1 (en) Aza-indazole or diaza-indazole derivatives for the treatment of pain
MX344335B (en) Benzonitrile derivatives as kinase inhibitors.
EA201491391A1 (en) THERAPEUTICALLY ACTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION
HRP20090235B1 (en) Carbonylated (aza) cyclohexanes as dopamine dreceptor ligands
EA201692166A1 (en) GLETAMINASE HETEROCYCLIC INHIBITORS
EA201270373A1 (en) JAK2 INHIBITORS AND THEIR APPLICATION FOR THE TREATMENT OF MYELOPROLIFERATIVE DISEASES AND MALIGNANT TUMOR
MA37886A1 (en) New bicyclic pyridinones
MA35663B1 (en) Derivatives of [1, 2, 3] triazolo [4,5-d] pyrimidine as cannabinoid receptor agonists 2
EA201492069A1 (en) TRIAZOLE COMPOUNDS AS PHOSPHODESTERASE 10 INHIBITORS (PDE10) INHIBITORS
IN2014MN02082A (en)
IN2014DN08886A (en)
MA39152A1 (en) 1,2-substituted cyclopentanes used as orexin receptor antagonists
EA201400858A1 (en) FUNGICIDE PYRMIDIN COMPOUNDS
MA35816B1 (en) Aniline derivatives, their preparation and their therapeutic application